At Bright Peak we are using our world-class protein engineering capabilities to create the next-generation of multifunctional precision immunotherapies.
Using our proprietary chemical protein synthesis platform, we are developing an emerging portfolio of novel designer immunotherapies for the treatment of cancer and autoimmune diseases.
Photo: David Walter, SENN
'